Trials / Terminated
TerminatedNCT05019105
Phase 1 ALKS 1140 in Healthy Adults
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Escalating Doses of ALKS 1140 With a Pilot Evaluation of Food Effect in Healthy Adult Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Alkermes, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and tolerability of ALKS 1140 in healthy adult subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Oral matching placebo |
| DRUG | ALKS 1140 | Active oral dose of ALKS 1140 |
Timeline
- Start date
- 2021-10-13
- Primary completion
- 2022-08-23
- Completion
- 2022-08-23
- First posted
- 2021-08-24
- Last updated
- 2022-09-02
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05019105. Inclusion in this directory is not an endorsement.